Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Psilocybin

Psilocybin boosts mind perception but doesn’t reduce atheism

by Mane Kara-Yakoubian
September 25, 2024
in Psilocybin
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook

A recent study published in Journal of Psychoactive Drugs found that while psychedelic experiences increased mind perception across various entities, they did not significantly change individuals’ Atheist-Believer status.

The relationship between psychedelics and belief systems has long fascinated researchers, particularly the possibility that psychedelics like psilocybin might alter spiritual or religious beliefs. Previous cross-sectional studies suggested that psychedelic experiences could lead to shifts in metaphysical beliefs or religious identifications, with some participants reporting increased spirituality and reduced atheism after using these substances. However, these earlier studies had various biases, such as relying on retrospective accounts and self-selection among participants already interested in belief changes.

Sandeep M. Nayak and colleagues addressed these limitations by conducting a prospective longitudinal study to assess how psilocybin, a well-known psychedelic, impacts belief systems and mind perception.

The researchers conducted a prospective longitudinal study, recruiting 657 participants who had planned to undergo a psilocybin experience outside of controlled laboratory settings. The recruitment materials did not mention belief changes to avoid priming participants about potential outcomes related to their spiritual or religious views.

Participants were asked to complete surveys at multiple time points: during informed consent (baseline), two weeks before their scheduled psilocybin experience, 2-4 weeks after the experience, and again 2-3 months later. These surveys collected a wide range of data, including demographic information and specifics related to their psilocybin use, such as dosage, setting, and ingestion method, and assessments of mind perception (e.g., attribution of consciousness to various living and non-living entities), metaphysical beliefs (e.g., materialism, dualism), and Atheist-Believer status (non-believer, agnostic, or believer).

The mind perception scale measured participants’ views on the conscious experience of various entities, ranging from non-human animals and plants to inanimate objects like rocks. The metaphysical beliefs scale included items that assessed participants’ views on the nature of reality, such as whether they believed in dualism (the separation of mind and body) or materialism (the belief that all phenomena have a material explanation). The Atheist-Believer scale captured participants’ religious affiliations or spiritual beliefs before and after the psilocybin experience.

The results revealed an increase in participants’ attribution of consciousness to various living and non-living entities following their psilocybin experience, particularly non-human primates, quadrupeds (e.g., dogs and cats), insects, fungi, and plants. These shifts in mind perception were evident both at the 2-4 week follow-up and again at 2-3 months.

Participants who were psychedelic-naive—those experiencing psilocybin for the first time—showed greater increases in mind perception than those with prior psychedelic experience. In contrast, there was little to no change in participants’ metaphysical beliefs; the belief that mind and body are distinct (dualism) or that material phenomena stem from the mind (idealism) remained stable. A small increase in determinism (the belief that events are pre-determined) was observed at the 2-3 month follow-up.

Google News Preferences Add PsyPost to your preferred sources

Participants’ Atheist-Believer status also remained unchanged, with no significant shifts in the proportions of non-believers, agnostics, or believers, contradicting earlier studies that suggested psilocybin might increase spirituality or reduce atheism. Overall, the findings suggest that psilocybin’s effect on mind perception is stronger than its influence on core spiritual or philosophical beliefs.

Of note is that this study lacked a non-psychedelic control group, making it harder to distinguish whether the observed changes were specifically due to psilocybin.

The research, “Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study”, was authored by Sandeep M. Nayak, Sydney H. White, Samantha N. Hilbert, Matthew X. Lowe, Heather Jackson, Roland R. Griffiths, Albert Garcia-Romeu, and David B. Yaden.

Previous Post

Scientists discover troubling brain changes in COVID-19 patients who lost sense of smell

Next Post

Fantasy Football’s surprising relationship with mental health

RELATED

New research: AI models tend to reflect the political ideologies of their creators
Neuroimaging

Psilocybin produces different behavioral and brain-altering effects depending on the dose

February 26, 2026
Cannabis use associated with better decision-making skills in people with bipolar disorder
Psilocybin

Low-dose psilocybin reduces weight gain and hyperglycemia in mice fed obesogenic diet

February 16, 2026
One specific reason for having sex is associated with higher stress levels the next day
Psilocybin

Psilocybin impacts immunity and behavior differently depending on diet and exercise context

February 4, 2026
Surprising link found between hyperthyroidism and dark personality traits
Depression

Long-term antidepressant effects of psilocybin linked to functional brain changes

January 31, 2026
Major new study finds psilocybin microdoses improve the quality of creative ideas but not the quantity
Microdosing

Major new study finds psilocybin microdoses improve the quality of creative ideas but not the quantity

January 24, 2026
How credible is psilocybin-assisted therapy? Study suggests people are cautious about psychedelic treatment for depression
Psilocybin

Psilocybin shows promise for rapid reduction of cancer-related depression

December 28, 2025
Single moderate dose of psilocybin linked to temporary reduction in OCD symptoms
Psilocybin

Single moderate dose of psilocybin linked to temporary reduction in OCD symptoms

December 21, 2025
Childhood adversity linked to poorer cognitive function across different patterns of aging
Anxiety

Psilocybin helps the brain unlearn fear by silencing specific neural pathways

December 8, 2025

STAY CONNECTED

LATEST

Entitled and exploitative people are more likely to treat others as objects, study finds

Brain scans of Buddhist monks reveal how different meditation styles alter consciousness

Republican rhetoric on mass shootings does not change public opinion on gun reform

Psychologists test the popular belief that you must love yourself to love a partner

Multiple childhood traumas linked to highly interconnected addictive behaviors in adulthood

War leaves most adults in Gaza with severe mental health conditions

Childhood ADHD medication is linked to slight changes in adult height and weight

Growing up with solid cooking fuels linked to long-term brain health risks

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc